EPCNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
EDGEWELL PERSONAL CARE Co
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$27.80−0.11 (-0.39%)
Close on Oct 19, 2026
- Market cap
- $1.30B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
41.6%−3.6 pts over 5 years
Operating margin
4.3%−4.7 pts over 5 years
Net margin
1.1%−2.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -1.3% | +0.8% | +2.7% | -0.8% | |
| Gross profit | -3.2% | +1.7% | +1.0% | -2.4% | |
| Operating income | -51.5% | -19.1% | -11.3% | – | |
| Net income | -74.2% | -36.6% | -17.8% | – | |
| EPS, diluted | -73.1% | -34.1% | -15.6% | – | |
| Free cash flow | – | -3.2% | -25.9% | -1.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 9.7% | 4.9% | 1.6% | |
| Return on assets | 3.7% | 1.9% | 0.7% | |
| Current ratio | 1.67 | 1.93 | 1.76 | |
| Debt to equity | 1.00 | 0.86 | 0.89 | |
| Net debt to EBITDA | – | 3.30× | 6.24× | |
| Interest coverage | – | 2.9× | 1.3× | |
| Inventory turnover | 3.7× | 3.2× | 2.9× | |
| Capex to revenue | 2.9% | 2.4% | 3.5% | |
| Diluted shares | 60M | 55M | 48M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Edgewell Personal Care generated $896.50M from operations and spent $804.30M on capital expenditure, dividends and share buybacks. 37% of that went back into the business.
Generated
$896.50M
Used
$804.30M
Capital expenditure$296.20M37%Dividends$149.70M19%Share buybacks$358.40M45%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin1.1%
×Asset turnover0.59×
×Equity multiplier2.39×
=Return on equity, FY20251.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 1.1% | 0.59× | 2.39× | 1.6% |
| FY2024 | 4.4% | 0.60× | 2.39× | 6.3% |
| FY2023 | 5.1% | 0.60× | 2.48× | 7.6% |
| FY2022 | 4.6% | 0.59× | 2.42× | 6.5% |
| FY2021 | 5.6% | 0.58× | 2.38× | 7.8% |
| FY2020 | 3.5% | 0.56× | 2.54× | 4.9% |
| FY2019 | -17.4% | 0.58× | 2.42× | -24.4% |
| FY2018 | 4.6% | 0.55× | 2.34× | 5.9% |
| FY2017 | 0.2% | 0.51× | 2.51× | 0.3% |
| FY2016 | 7.6% | 0.48× | 2.64× | 9.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$25.40M
- Cash generatingOperating cash flow above zero$118.40M
- Return on assets improvedROA up on the prior year2.6% → 0.7%
- Earnings backed by cashOperating cash flow above net income$118.40M vs $25.40M
- Less leverageLong-term debt to assets fell34.2% → 36.8%
- Better liquidityCurrent ratio rose1.66 → 1.76
- No dilutionShare count did not rise50M → 48M
- Gross margin improvedGross margin up on the prior year42.41% → 41.60%
- More efficientAsset turnover rose0.60 → 0.60